Clinical chorioamnionitis continues to contribute to fetal and maternal morbidity and mortality. Significant advances have been made in the last 20 years in understanding the pathophysiologic processes leading to chorioamnionitis. This review addresses the history, incidence, pathophysiology, host defenses, risk factors, diagnosis, and maternal and neonatal management of clinically evident chorioamnionitis. After a detailed review of the physiologic processes leading to clinical chorioamnionitis and sepsis, we present a modern management scheme designed to optimize perinatal outcome for both mother and fetus. (C) 
Seventy percent of the patients with clinically evident infection had >100 CFU/ml of virulent organisms compared with only 8% of the controls. The most common organisms noted were anaerobes and group B streptococci. Gravett et al. 6 have noted similar findings. The distribution of organisms in over 400 cases of chorioamnionitis can be seen in Table 1 .
Interestingly, pregnancies with chorioamnionitis resulting in the births of newborns <2,500 g have been noted to contain significantly higher frequencies of anaerobic organisms such as Bacteroides bivius and Fusobacterium than term controls but similar frequencies of gram-negative enterics and group B streptococci. One can speculate that these anaerobes may asymptomatically ascend to the uterine cavity and initiate preterm labor and delivery through deciduitis and expression of humoral factors such as tumor necrosis factor (TNF), interleukins, and other cytokines. Bejar et al. 17 29 studied 171 gravidas with clinical chorioamnionitis and noted no differences in the percentages of pregnancies with maternal or neonatal bacteremia when the diagnosis-to-delivery intervals were arbitrarily broken into 4-h increments. However, < 10% of their fetuses were delivered >12 h after the diagnosis. Hauth et al. 23 studied 103 gravidas with clinical chorioamnionitis in whom no differences in neonatal outcome were noted when the diagnosis-to-delivery intervals were increased from h up to 10 h. Again, however, only 2% of their patients were delivered after 10 h. It appears from the above data that a diagnosis-to-delivery interval of up to 12 h is not associated with increased neonatal morbidity (assuming that the mother is receiving parenteral antibiotics). However, the risks to the fetus, if a delay beyond 12 20 years has enabled us to characterize the epidemiology and molecular pathophysiology leading to this infection. Unfortunately, we currently cannot establish the diagnosis until the infection is clinically evident, resulting in alterations in the normal maternal-fetal homeostasis. Current topics of research include assessments of primary prevention such as vaccination with group B streptococcal antigen, early identification of at-risk parturients using clinical paradigms or rapid detection antigen assays, and determination of the optimal type and mode of delivery of antibiotics.
